Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure: A Cohort Study
- 1 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (5) , e010416
Abstract
BACKGROUND: Although frailty is strongly associated with mortality in patients with heart failure (HF), the risk of which specific cause of death is associated with being complicated with frailty is unclear. We aimed to clarify the association between multidomain frailty and the causes of death in elderly patients hospitalized with HF. METHODS: We analyzed data from the FRAGILE-HF cohort, where patients aged 65 years and older, hospitalized with HF, were prospectively registered between 2016 and 2018 in 15 Japanese hospitals before discharge and followed up for 2 years. All patients were assessed for physical, social, and cognitive dysfunction, and categorized into 3 groups based on their number of frailty domains (FDs, 0–1, 2, and 3). Kaplan-Meier survival analysis was used to evaluate the association between the number of FDs and all-cause mortality, whereas Fine-Gray competing risk regression analysis was used for assessing the impact on cause-specific mortality. RESULTS: We analyzed 1181 patients with HF (81 years old in median, 57.4% were male), 530 (44.9%), 437 (37.0%), and 214 (18.1%) of whom were categorized into the FD 0 to 1, FD 2, and FD 3 groups, respectively. During the 2-year follow-up, 240 deaths were observed (99 HF deaths, 34 cardiovascular deaths, and 107 noncardiovascular deaths), and an increase in the number of FD was significantly associated with mortality (Log-rank: P <0.001). The Fine-Gray competing risk analysis adjusted for age and sex showed that FDs 2 (subdistribution hazard ratio, 1.77 [95% CI, 1.11–2.81]) and 3 (2.78, [95% CI, 1.69–4.59]) groups were associated with higher incidence of noncardiovascular death but not with HF and other cardiovascular deaths. CONCLUSIONS: Although multidomain frailty is strongly associated with mortality in older patients with HF, it is mostly attributable to noncardiovascular death and not cardiovascular death, including HF death. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: UMIN000023929Keywords
This publication has 43 references indexed in Scilit:
- Cardiovascular vs. Non-Cardiovascular Deaths After Heart Failure Hospitalization in Young, Older, and Very Old PatientsESC Heart Failure, 2022
- Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection FractionJAMA Cardiology, 2022
- Multimorbidity, Guideline-Directed Medical Therapies, and Associated Outcomes Among Hospitalized Heart Failure PatientsESC Heart Failure, 2022
- Prevalence and Prognostic Impact of Cognitive Frailty in Elderly Patients with Heart Failure: Sub-Analysis of FRAGILE-HFESC Heart Failure, 2022
- Mode of death in elderly and super‐elderly patients with acute heart failure: Insights from Japanese heart failure registryClinical Cardiology, 2021
- Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failureClinical Research in Cardiology, 2021
- Prevalence and Prognostic Impact of the Coexistence of Multiple Frailty Domains in Elderly Patients with Heart Failure: The FRAGILE-HF Cohort StudyEuropean Journal of Heart Failure, 2020
- Trends in Modes of Death in Heart Failure Over the Last Two Decades: Less Sudden Death but Cancer Deaths on the RiseEuropean Journal of Heart Failure, 2019
- Performance of the MAGGIC Heart Failure Risk Score and its Modification with the Addition of Discharge Natriuretic PeptidesESC Heart Failure, 2018
- Practical recommendations for reportingFine‐Gray model analyses for competing risk dataStatistics in Medicine, 2017